TickerFacts.

Company research / CGEN

Compugen Ltd (CGEN)

Build a valuation ↗↓ Download CSV

SEC name COMPUGEN LTD · CIK 0001119774 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Compugen Ltd reported revenue of $72.76M. Revenue grew 161.1% from the prior annual period.

Key ratios (year ended 2025-12-31)

87.3%
Gross margin
43.1%
Operating margin
48.6%
Net margin
34.4%
Return on year-end equity
161.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$72.76M$27.86M$33.46M$7.50M$6.00M$2.00Mn/a$17.80Mn/a$712.0K
Cost of Revenue$9.25M$7.93M$2.00M$975.0K$680.0K$60.0Kn/a$1.03Mn/a$223.0K
Gross Profit$63.51M$19.93M$31.45M$6.53M$5.32M$1.94Mn/a$16.77Mn/a$489.0K
R&D Expense$22.76M$24.81M$34.47M$30.65M$28.69M$22.76M$19.82M$30.32M$28.58M$24.55M
Operating Income$31.33M-$14.89M-$12.99M-$35.37M-$35.07M-$31.50M-$28.88M-$23.23M-$37.41M-$32.58M
Net Income$35.34M-$14.23M-$18.75M-$33.69M-$34.20M-$29.70M-$27.34M-$22.60M-$37.07M-$31.51M
EPS (Diluted)$0.38-$0.16-$0.21-$0.39-$0.41-$0.37-$0.43-$0.41-$0.72-$0.62
Total Assets$156.57M$115.00M$121.33M$94.18M$132.16M$138.32M$53.76M$53.18M$38.75M$71.14M
Shareholders' Equity$102.73M$54.91M$65.56M$77.68M$106.69M$119.78M$38.32M$37.24M$29.30M$63.52M
Cash & Equivalents$90.60M$18.23M$13.89M$11.06M$7.80M$7.14M$9.19M$5.86M$25.47M$9.71M
Operating Cash Flow$31.63M$49.60M-$35.89M-$34.11M-$22.69M-$28.32M-$27.89M-$13.29M-$30.66M-$19.82M
Capital Expenditures$306.0K$118.0K$172.0K$477.0K$292.0K$166.0K$155.0K$158.0K$385.0K$2.60M
Free Cash Flow$31.33M$49.49M-$36.06M-$34.59M-$22.98M-$28.49M-$28.04M-$13.45M-$31.04M-$22.42M
Shares Outstanding94.55M89.54M89.24M86.62M86.43M83.68M67.92M59.85M51.29M51.13M
Weighted Average Diluted Shares93.82M89.53M87.63M86.56M84.20M79.59M63.64M55.28M51.18M50.86M
EPS (Basic)$0.38-$0.16-$0.21-$0.39-$0.41-$0.37-$0.43-$0.41-$0.72-$0.62

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView